Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the American College of Cardiology

• Publication date

  2009-02-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2008.09.054PMID 19179217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin as an anti-inflammatory and antiatherogenic modulator.

  2009cited by this paper
• Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

  2008cited by this paper
• Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism

  2008cited by this paper
• Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study.

  2007cited by this paper
• A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events

  2007cited by this paper
• Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

  2007cited by this paper
• Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

  2007cited by this paper
• Impact of introducing multiple evidence-based clinical practice protocols in a medical intensive care unit: a retrospective cohort study

  2007cited by this paper
• Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature

  2006cited by this paper
• The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

  2006cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006cited by this paper
• Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.

  2006cited by this paper
• Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial

  2006cited by this paper
• A Pilot Study of the SPRINT Protocol for Tight Glycemic Control in Critically Ill Patients

  2006cited by this paper
• Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

  2005cited by this paper
• Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.

  2005cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.

  2004cited by this paper
• Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction

  2004cited by this paper
• Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events

  2004cited by this paper
• C-reactive protein levels following acute myocardial infarction: effect of insulin infusion and tight glycemic control.

  2004cited by this paper
• Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era.

  2004cited by this paper
• Insulin, glycemic control, and C-reactive protein during myocardial infarction.

  2004cited by this paper
• Role of intravenous insulin therapy in critically ill patients.

  2004cited by this paper
• Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.

  2004cited by this paper
• Role of intravenous insulin therapy in critically ill patients.

  2004cited by this paper
• Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

  2003cited by this paper
• Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

  2002cited by this paper
• Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

  2002cited by this paper
• Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

  2000influential reference
• Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in

  1999cited by this paper
• Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo.

  1997cited by this paper
• Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting.

  1997cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction.

  1996cited by this paper
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

  1995cited by this paper
• Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group.

  1993cited by this paper
• In-Hospital Prognosis of Ppatients With Fasting Hyperglycemia After First Myocardial Infarction

  1991cited by this paper
• Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus.

  1989cited by this paper
• Stress hyperglycemia and cause of death in non-diabetic patients with myocardial infarction.

  1987cited by this paper
• Relation between phenotype and banal melanocytic naevi.

  1987cited by this paper
• Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction

  1979cited by this paper
• Hyperglycemia during acute myocardial infarction. A six-year follow-up study.

  1975cited by this paper
• Hyperglycemia During Acute Myocardial Infarction: A Six-Year Follow-up Study

  1975cited by this paper
• Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size.

  1975cited by this paper
• Induction of ventricular arrhythmias by elevation of arterial free fatty acids in experimental myocardial infarction.

  1971cited by this paper
• The Role of Free Fatty Acids in the Production of Ventricular Arrhythmias after Acute Coronary Artery Occlusion

  1971cited by this paper
• CORONARY THROMBOSIS AND MYOCARDIAL INFARCTION, WITH GLYCOSURIA

  1931cited by this paper

• The Role of Remote Glucose Management Using Real-time Continuous Glucose Monitoring Systems in ICU-hospitalized Patients with COVID-19

  2025cites this paper
• The Glucose-to-Lymphocyte Ratio Predicts All-cause Mortality and Cardiovascular Mortality in ST-Elevation Myocardial Infarction Patients: A Retrospective Study

  2025cites this paper
• Impact of admission glucose and 30-day major adverse cardiovascular events on patients with chest pain in an emergency setting: insights from the China EMPACT registry

  2024cites this paper
• The relationship between COVID-19 and hyperglycemia: screening and monitoring hospitalized patients

  2024cites this paper
• Prognostic significance of the stress hyperglycemia ratio in critically ill patients

  2023cites this paper
• Risk factors for hyperglycemia in COVID‐19 patients treated with remdesivir

  2023cites this paper
• Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity

  2022cites this paper
• World Journal of Critical Care Medicine

  2022cites this paper
• An insight to the incidence of acute pancreatitis, and co-morbidity of diabetes in SARS-COV2 infection

  2022cites this paper
• Challenges in hyperglycemia management in critically ill patients with COVID-19

  2022cites this paper
• Diabetes predicts severity of COVID‐19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C‐reactive protein

  2021cites this paper
• High-dose insulin infusion in patients with COVID-19

  2021cites this paper
• Immunometabolic bases of type 2 diabetes in the severity of COVID-19

  2021cites this paper
• Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study

  2021cites this paper
• COVID-19 and Preexisted Diabetes , One Insults the Other “ Narrative Review ”

  2021cites this paper
• High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.

  2021cites this paper
• Pharmacological management of COVID-19 in type 2 diabetes

  2021cites this paper
• The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome

  2021cites this paper
• A single arm trial using passive simulated jogging for blunting acute hyperglycemia

  2021cites this paper
• Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU

  2021cites this paper
• The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction

  2020cites this paper
• Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory

  2020cites this paper
• Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era

  2020cites this paper
• Why is hyperglycaemia worsening COVID‐19 and its prognosis?

  2020cites this paper
• Issues for the management of people with diabetes and COVID-19 in ICU

  2020cites this paper
• Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405–13)

  2020cites this paper
• The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients

  2020cites this paper
• Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature

  2020cites this paper
• Effectiveness of an educational intervention on the management of type 2 diabetic patients hospitalized in Internal Medicine: results from the FADOI-DIAMOND study

  2014cites this paper
• The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report

  2014cites this paper
• Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction.

  2014cites this paper
• Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes

  2014cites this paper
• The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia

  2013cites this paper
• Acute glucose dysmetabolism in the elderly with ST elevation myocardial infarction submitted to mechanical revascularization.

  2012cites this paper
• Early improvement in carotid plaque echogenicity by acarbose in patients with acute coronary syndromes.

  2012cites this paper
• Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction

  2011cites this paper
• The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction

  2011cites this paper
• Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy

  2010cites this paper
• Controversies in the Treatment of Sepsis

  2010cites this paper
• Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent

  2010cites this paper
• In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes

  2010cites this paper
• Carbohydrate nutrition and inflammatory disease mortality in older adults.

  2010cites this paper
• Diabetes and cardiovascular outcomes: finding the silver lining.

  2010cites this paper
• Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent

  2010cites this paper
• Controle glicêmico em terapia intensiva 2009: sem sustos e sem surpresas

  2009cites this paper
• Glucose control in critically ill patients in 2009: no alarms and no surprises.

  2009cites this paper
• Insulin as a cardiovascular therapeutic: improving glycemic control in patients with coronary artery disease.

  2009cites this paper
• Strict glucose control in the cardiac intensive care unit poised for real time?

  2009cites this paper
• Tight glycemic control and point-of-care testing.

  2009cites this paper